Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-08-26 10:01 am Unchanged | 2024-08-26 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | Arkin Moshe | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-07-01 06:47 am Unchanged | 2024-07-01 | 13D | Eiger BioPharmaceuticals, Inc. EIGR | Arkin Moshe | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-05-10 2:14 pm Unchanged | 2024-05-10 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | AMERIPRISE FINANCIAL INC AMP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-14 4:03 pm Unchanged | 2024-02-14 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | 683 Capital Management LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-14 10:55 am Unchanged | 2024-02-14 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | AMERIPRISE FINANCIAL INC AMP | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-12-04 06:01 am Unchanged | 2023-12-04 | 13D | Eiger BioPharmaceuticals, Inc. EIGR | Arkin Moshe | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-11-24 06:01 am Unchanged | 2023-11-24 | 13D | Eiger BioPharmaceuticals, Inc. EIGR | Arkin Moshe | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-11-02 9:54 pm Unchanged | 2023-11-02 | 13D | Eiger BioPharmaceuticals, Inc. EIGR | Propel Bio Management LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-10-20 4:29 pm Unchanged | 2023-10-20 | 13D | Eiger BioPharmaceuticals, Inc. EIGR | Propel Bio Management LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-09-28 4:54 pm Unchanged | 2023-09-28 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | Propel Bio Management LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-08-15 06:00 am Unchanged | 2023-08-15 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | Propel Bio Management LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-07-07 4:35 pm Unchanged | 2023-07-07 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | BlackRock Inc. BLK | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-04-18 09:59 am Unchanged | 2023-04-18 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | Arkin Moshe | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-04-10 1:37 pm Unchanged | 2023-04-10 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | AMERIPRISE FINANCIAL INC AMP | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 2:23 pm Unchanged | 2023-02-14 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | 683 Capital Management LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-09 10:57 am Unchanged | 2023-02-09 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-06 3:34 pm Unchanged | 2023-02-06 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | BlackRock Inc. BLK | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-02 2:25 pm Unchanged | 2023-02-02 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | Arkin Moshe | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-01-10 12:12 pm Unchanged | 2023-01-10 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | AMERIPRISE FINANCIAL INC AMP | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-05-11 3:01 pm Unchanged | 2022-05-11 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | AMERIPRISE FINANCIAL INC AMP | 0 0.000% | 0 (Unchanged) | Filing |